MIA researchers feature on prestigious Highly Cited Researchers 2021 List
19 November 2021
Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, as well as MIA Faculty members Associate Professor Alex Menzies and Associate Professor Matt Carlino, and former Faculty member Professor Rick Kefford AM, have all been named on the annual Highly Cited Researchers™ 2021 list from Clarivate.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies the ‘One in 1,000’ Citation Elite – the researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.
According to Clarivate, 6,602 researchers from more than 70 countries and regions have been recognized this year. Australia has narrowly overtaken Germany to come in fourth, with 332 researchers making the list- remarkable for a country of 25 million compared with Germany’s 83 million.
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:
‘It is increasingly important for nations and institutions to recognize and support the exceptional researchers who are driving the expansion of the world’s knowledge. This list identifies and celebrates exceptional individual researchers at Melanoma Institute Australia who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. The research they have contributed is fuelling the innovation, sustainability, health and security that is key for our society’s future.’
Melanoma Institute Australia CEO Matthew Browne said the inclusion of four current members of MIA’s Faculty on the global list for the second year running was indicative of our standing on the world stage.
‘To have MIA researchers feature so prominently in the ‘who’s who’ of the world’s scientific elite shows the life-changing impact of our work not only in Australia but internationally,’ he said. ‘Under the leadership of our Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, MIA continues to reach new heights and spearhead the world towards a cure for not only melanoma, but increasingly other complex skin cancers as well. On behalf of the entire MIA team, and our patients, their families and our wonderfully supportive community and donors, I extend my heartfelt congratulations to our four Faculty members named on the Highly Cited Researchers list.’
The full 2021 Highly Cited Researchers list and executive summary can be found online here.
Melanoma Institute Australia is affiliated with The University of Sydney
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.